Please wait while the formulary information is being retrieved.
DRISTAN (OXYMETAZOLINE HCL)
- Nasal congestion
- Vicks Sinex Ultra Fine Mist 12-hour Nasal Spray
- Vicks Qlearquil Nasal Mist
- Sinus Relief Nasal Mist
- Sinus Relief (oxymetazoline) Nasal Mist
- No Drip Nasal Mist
- Nasal Spray 12 Hour Mist
- Dristan Long Lasting Nasal Mist
- Anefrin Nasal Mist
- Afrin Sinus No Drip Nasal Mist
- Afrin No Drip (oxymetazoline) Nasal Mist
Vicks 0.05 % nasal spray
- Dosage information is not available
Vicks QlearQuil 0.05 % nasal mist
- Dosage information is not available
(oxymetazoline) 0.05 % nasal mist
- Dosage information is not available
(oxymetazoline) 0.05 % nasal mist
- Dosage information is not available
0.05 %
- Dosage information is not available
12 Hour 0.05 % mist
- Dosage information is not available
Long Lasting 0.05 % nasal mist
- Dosage information is not available
0.05 % nasal mist
- Dosage information is not available
No Drip (oxymetazoline) 0.05 % nasal mist
- Dosage information is not available
No Drip (oxymetazoline) 0.05 % nasal mist
- Dosage information is not available
- None
Contraindicated
- bromocriptine
- cabergoline
- Cafergot
- Compound 347
- Cycloset
- D.h.e.45
- dihydroergotamine
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- isoflurane
- methylergonovine
- Migergot
- Migranal
- Parlodel
- sevoflurane
- Sojourn
- Terrell
- Ultane
Severe
Moderate
- None
- None
Contraindicated
- Angle-closure glaucoma
- Benign prostatic hyperplasia
Severe
Moderate
- Atherosclerotic cardiovascular disease
- Cardiac disease
- Coronary artery disease
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
DRISTAN (OXYMETAZOLINE HCL)
- Nasal congestion
- None
- None
More Frequent
Severe
Less Severe
- Dizziness
- Headache disorder
- Insomnia
- Nervousness
- Rebound nasal congestion
- Tremor
- Dry nose
- Nasal passage irritation
- Rhinorrhea
- Sneezing
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Cardiac arrhythmia
- Hypertension
Less Severe
- Nausea
- Palpitations
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Oxymetazoline (nasal,ophth)
Recommend clinician evaluation prior to use under 6 years of age.
- 1 Day – 6 Years
- Recommend clinician evaluation prior to use under 6 years of age.
Oxymetazoline (ophth, Nasal)
- Severity Level:
2
- Additional Notes: May potentially constrict uterine blood vessels, producing fetal hypoxia
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Oxymetazoline (ophth, Nasal)
Insufficient data available.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Nasal congestion | |
| R09.81 | Nasal congestion |
| 0-9 | A-Z |
|---|---|
| R09.81 | Nasal congestion |
Formulary Reference Tool